Srs Capital Advisors, Inc. Johnson & Johnson Transaction History

Srs Capital Advisors, Inc.

$1.07 Billion
Q3 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 15,479 shares of JNJ stock, worth $2.25 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

15,479

Previous 15,621 0.91%

Holding current value

$2.25 Million

Previous $2.28 Million 9.86%

% of portfolio

0.24%

Previous 0.23%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$145.48 - $167.38 $20,658 - $23,767	-142 Reduced 0.91%	15,479 $2.51 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $51,399 - $56,169	356 Added 2.33%	15,621 $2.28 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $276,136 - $289,514	-1,779 Reduced 10.44%	15,265 $2.41 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $35,817 - $39,084	-246 Reduced 1.42%	17,044 $2.67 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $8,877 - $9,945	-57 Reduced 0.33%	17,290 $2.69 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $11,267 - $12,126	73 Added 0.42%	17,347 $2.87 Million
Q1 2023 May 16, 2023	SELL	$151.05 - $180.26 $11,177 - $13,339	-74 Reduced 0.43%	17,274 $2.68 Million
Q4 2022 Feb 24, 2023	SELL	$160.2 - $179.79 $16,660 - $18,698	-104 Reduced 0.6%	17,348 $3.06 Million
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $157,619 - $175,391	977 Added 5.93%	17,452 $2.85 Million
Q2 2022 Aug 22, 2022	BUY	$168.19 - $186.01 $89,813 - $99,329	534 Added 3.35%	16,475 $2.93 Million
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $1,581 - $1,795	10 Added 0.06%	15,941 $2.83 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $6,860 - $7,612	44 Added 0.28%	15,931 $2.73 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $38,275 - $42,534	237 Added 1.51%	15,887 $2.57 Million
Q2 2021 Aug 02, 2021	BUY	$159.48 - $171.07 $21,370 - $22,923	134 Added 0.86%	15,650 $2.58 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $94,756 - $103,835	-675 Reduced 4.17%	15,516 $2.31 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $98,926 - $119,431	-768 Reduced 4.53%	16,191 $2.28 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $61,349 - $85,002	-552 Reduced 3.15%	16,959 $2.22 Million
Q4 2019 Feb 07, 2020	BUY	$127.5 - $146.44 $7,522 - $8,639	59 Added 0.34%	17,511 $2.55 Million
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $10,029 - $11,229	79 Added 0.45%	17,452 $2.26 Million
Q2 2019 Aug 08, 2019	SELL	$131.15 - $144.24 $181,511 - $199,628	-1,384 Reduced 7.38%	17,373 $2.42 Million
Q4 2018 Feb 06, 2019	BUY	$122.84 - $147.84 $196,052 - $235,952	1,596 Added 9.3%	18,757 $2.42 Million
Q3 2018 Nov 06, 2018	SELL	$121.58 - $142.88 $918,050 - $1.08 Million	-7,551 Reduced 30.56%	17,161 $2.37 Million
Q2 2018 Aug 21, 2018	BUY	$119.4 - $131.76 $1.23 Million - $1.35 Million	10,272 Added 71.14%	24,712 $3 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $143,364 - $169,768	-1,146 Reduced 7.35%	14,440 $1.85 Million
Q4 2017 Feb 15, 2018	BUY	$131.22 - $143.62 $1 Million - $1.09 Million	7,623 Added 95.73%	15,586 $2.18 Million
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $1.03 Million - $1.08 Million	7,963	7,963 $1.04 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Johnson & Johnson Transaction History